Magnus Aurivillius

3PUBLICATIONS
7CO-AUTHORS
Pharmaceutical delivery technologiesBehavioural epidemiologyPsycholinguistics (incl. speech production and comprehension)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Feb 12, 2026
Bioequivalence of budesonide/glycopyrrolate/formoterol fumarate with a next-generation propellant versus hydrofluoroalkane-134a in healthy adults: phase I, randomized, double-blind, single-dose, partial-replicate, three-way cross-over lung exposure and total systemic exposure studies.

Artur Bednarczyk, Magnus Aurivillius, Mandeep Jassal

|Dec 13, 2022
Benefits of Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate on COPD Exacerbations, Lung Function, Symptoms, and Quality of Life Across Blood Eosinophil Ranges: A Post-Hoc Analysis of Data from ETHOS.

Mona Bafadhel, Klaus F Rabe, Fernando J Martinez

|Jul 11, 2022
Effect of inhaled budesonide/formoterol fumarate dihydrate delivered via two different devices on lung function in patients with COPD and low peak inspiratory flow.

Bärbel Huber, Claus Keller, Martin Jenkins

Pageof 1

Frequent Collaborators

1 joint publications

Mona Bafadhel

1 joint publications

Klaus F Rabe

1 joint publications

Fernando J Martinez

1 joint publications

Dave Singh